Israel Englander’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Israel Englander’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64M	Sell	403,300 -53,200	-12%	-$7.91M	0.02%	742
2026 Q1	$66.9M	Sell	456,500 -153,600	-25%	-$23.7M	0.03%	657
2025 Q4	$94.4M	Buy	610,100 +232,600	+62%	+$34.8M	0.04%	457
2025 Q3	$52.5M	Buy	377,500 +24,200	+7%	+$3.27M	0.02%	833
2025 Q2	$47.6M	Sell	353,300 -346,800	-50%	-$46.8M	0.02%	850
2025 Q1	$102M	Sell	700,100 -146,700	-17%	-$21.3M	0.05%	341
2024 Q4	$116M	Buy	846,800 +261,200	+45%	+$38.2M	0.06%	337
2024 Q3	$90.2M	Buy	585,600 +195,200	+50%	+$29.6M	0.04%	475
2024 Q2	$56.9M	Sell	390,400 -104,200	-21%	-$14.9M	0.03%	718
2024 Q1	$73.1M	Sell	494,600 -265,000	-35%	-$38M	0.03%	619
2023 Q4	$104M	Buy	759,600 +503,900	+197%	+$65.6M	0.04%	405
2023 Q3	$32.9M	Buy	255,700 +6,600	+3%	+$876K	0.02%	1022
2023 Q2	$33.1M	Sell	249,100 -1,269,600	-84%	-$167M	0.02%	1009
2023 Q1	$197M	Sell	1,518,700 -547,900	-27%	-$71.6M	0.11%	123
2022 Q4	$281M	Buy	2,066,600 +407,100	+25%	+$53.9M	0.16%	78
2022 Q3	$201M	Sell	1,659,500 -64,200	-4%	-$8.27M	0.12%	103
2022 Q2	$221M	Sell	1,723,700 -387,800	-18%	-$50.8M	0.14%	74
2022 Q1	$289M	Buy	2,111,500 +1,189,900	+129%	+$158M	0.15%	66
2021 Q4	$130M	Buy	921,600 +309,600	+51%	+$41.1M	0.07%	256
2021 Q3	$77.9M	Buy	612,000 +460,000	+303%	+$60.8M	0.05%	410
2021 Q2	$19.1M	Buy	152,000 +3,900	+3%	+$478K	0.01%	1236
2021 Q1	$17.3M	Sell	148,100 -334,900	-69%	-$38.7M	0.01%	1217
2020 Q4	$54.8M	Buy	483,000 +3,000	+0.6%	+$327K	0.04%	413
2020 Q3	$50.6K	Buy	480,000 +293,600	+158%	+$30.9M	0.06%	309
2020 Q2	$18.7M	Sell	186,400 -459,000	-71%	-$45.3M	0.03%	774
2020 Q1	$57.2M	Buy	645,400 +426,800	+195%	+$41.5M	0.13%	138
2019 Q4	$22.3M	Sell	218,600 -359,200	-62%	-$34.5M	0.03%	778
2019 Q3	$52.1M	Buy	577,800 +484,300	+518%	+$44.2M	0.08%	292
2019 Q2	$8.66M	Buy	93,500 +59,800	+177%	+$5.38M	0.01%	1372
2019 Q1	$3.09M	Buy	33,700 +28,800	+588%	+$2.6M	﹤0.01%	2098
2018 Q4	$424K	Buy	+4,900	New	+$443K	﹤0.01%	3056

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Israel Englander's XLV Position: Q2 2026 in Review

Israel Englander reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 69% in Q2 2026, selling an estimated $59.3M and leaving 182,757 shares worth $29M. The position accounts for 0.01% of the portfolio, ranked #1292.

Israel Englander first reported a position in XLV in Q2 2013 and has held it in 53 quarters since. The position peaked at $305M in Q1 2023. 1,850 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Israel Englander held 182,757 shares of State Street Health Care Select Sector SPDR ETF worth $29M as of Q2 2026.
Israel Englander sold 398,410 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $59.3M.
State Street Health Care Select Sector SPDR ETF made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1292 holding.
Israel Englander first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 53 quarters since.
Israel Englander's State Street Health Care Select Sector SPDR ETF position peaked at $305M in Q1 2023.
1,850 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.